🚨 What to expect from the Fed tomorrow
High odds of a rate hold at 3.75-4.00%, but 80%+ odds of a hike in December
The real move comes at Warsh's 1:30pm CT press conference. A hawkish tone hits risk assets, a softer one sparks relief.
Rates move everything, #Bitcoin included

10.28 Jince Gold Morning Review: Gold surges 76 points and consolidates at highs; can bulls set a new high?

Spot gold staged a rebound after an early-session dip to a low of 3989. Bulls then surged, driving a one-way rally that broke through multiple resistance levels at 4000 and 4036, reaching a high near 4065. After the rally, prices entered narrow-range consolidation at elevated levels. The current quote is 4062, with bulls dominating overall and buying sentiment continuing to strengthen.
Technical analysis: On the 15-minute chart, prices are consolidating at high levels after a one-way r

$ZEC Current price: 1,308.27, 24H +6.32%. 1H is overbought (RSI78), but 4H remains strong, with EMA20 at 1,272/1,241. 1H resistance is at 1,318.31 and support at 1,210.49. Holding above resistance could lead to a push to new highs, while a break below support puts the 4H support at 1,118.55 in view. In the review, focus on whether a false breakout occurs at 1,318.31 or whether price can reclaim 1,210.49 after losing it. Current volume is only 0.64x, so continuation needs confirmation. Market volatility is high; for observation only.

$EVAA is poised for a sharp drop. Continue holding your short position, with a target price of 0.70 and a stop-loss price of 1.050. Welcome to join the bears.

$BLESS Set up a quick short trade now, and thank me later.🛑 Stop loss: 0.00970🎯 Take profit: 0.00850 Open a short position on $BLESS now 👇

Today’s NBA game picks on @Polymarket
don’t miss out:

Bitcoin drops below $80,000 as Iran tensions weigh on weekend sentiment
GM!
Morning Minute is a daily newsletter written by Tyler Warner. The analysis and opinions expressed are his own and do not necessarily reflect those of Decrypt. And check out our daily news show 'FOMO HOUR' covering all of the top stories and market action.
⚠️ Personal market analysis only. NFA — manage risk and DYOR.
Educational content, not investment advice or a recommendation to buy, sell, deposit, or withdraw any asset. No paid promotion or referral/affiliate links.

#GateSquareHalloween
Cardano’s (ADA) coin is trading at $0.2055 after ultra-soft intra-day gains helped the altcoin sustain above several moving averages. Cardano’s price bounced off the lower-tier Bollinger Band at $0.196, establishing a broader expansion of these mathematically-based envelopes

Bitcoin pumps 20% on average in October

$COAI Bulls push toward the $0.2700 area. Entry price: $0.2550–$0.2575. Take-profit 1: $0.2600. Take-profit 2: $0.2650. Take-profit 3: $0.2700. Stop-loss: $0.2500. Buy and trade $COAI

#GateFirstToLaunchGoldCFD7X23Trading #ShareWeekly
Gold Trading Beyond Traditional Market Hours: Can Gate’s 7×23 XAUUSD CFD Change the Way Traders Manage Risk?
Gold trading has always required patience, market awareness, and an understanding of global economic conditions. From Federal Reserve interest-rate decisions and inflation reports to movements in the US dollar and geopolitical tensions, several factors can influence gold prices within a short period.
However, traditional trading hours can create challenges when important developments occur outside regular sessions. Gate’s introduction o

The Musk-themed puppy token, puppies, appeared out of nowhere within a minute of Musk’s tweet, “l love you puppies.” Its contract address ends in 6eb2, and it is listed on more than a dozen exchanges. Communities in over 50 countries are continuing to build, making it worth accumulating at low levels

CT | Long 🟢 | Bullish | 15m | 24h: +14.01% | Volume: 40.9M USDT
Long rationale: Price is above EMA200; EMA20/50/200 are in bullish alignment; RSI14 is 56.7; MACD histogram is positive; ADX14 is 10.5; volume is 0.97x the 20-candle average; trend pullback/continuation.
Entry: 0.17029
Stop-loss: 0.167225
Take-profit 1: 0.174121 | Take-profit 2: 0.176419 | Take-profit 3: 0.179484
Entry price is for reference only; do not chase. Invalidate if the stop-loss level is hit. Technical analysis only; not investment advice. $C

$SNDK Honestly, I used to chase 100x gains, get liquidated, and stay up until 3 a.m. staring at candlesticks and cursing the market makers. Then I realized the market makers don't know me, and the market doesn't owe me money. I've survived this long purely because I got tired of losing—set stop-losses quickly, stick to my own strategy, and leave trades I shouldn't touch alone, even if it means sitting on the sidelines and watching. It's not that my technical skills have improved; I just understand more. In crypto, understanding is the core competitive edge.#BTC争夺8万美元关口

With the same 1000U, the outcomes can be worlds apart. After this 30-point plunge in $AGT today, can your spot holdings still take the hit? I’m a Gate Square PK analyst: I only talk competition, not feelings. The data is right here—see for yourself.
First, the 24-hour scorecard: high of 0.0701, low of 0.0452, current price 0.0456, down 30.96%, with 28.2M in trading volume. In other words, anyone who caught the falling knife in the morning had lost the price of an electric scooter by the close. 1000U invested at 0.0701 is now worth 650U; buying in at 0.0456 with 1000U—is that a bet on a rebound

I asked GPT and Grok.
They told me not to lend it. Sorry, bro🙏

Today's KOL performance leaderboard is out: all 22 signals have been settled, with 19 hits and 3 stop-losses. Topping the chart, “Stand Out and Get Rich for Sure” went 5 for 5, with a 100% win rate and simulated returns of +12064%; AMAN followed closely, going 7 for 7. See the image for the full leaderboard. By the way, last period (10-28), the top spot also went to Stand Out and Get Rich for Sure (+12064%), making it two consecutive wins 👀#Can Robinhood's trading business growth continue?

$ANT is not just an AI infrastructure bet anymore. The drug development research changes how investors should read the IPO.
Anthropic’s latest research update is not a product announcement. It is a statement of intent: the company has moved from selling AI tools to pharmaceutical partners into running its own drug discovery programs. For anyone looking at the $ANT IPO, that shift matters more than another benchmark score.
What the research actually shows. Anthropic has deep partnerships with six drug developers, including Bristol Myers Squibb, Generate Biomedicines, and BigHat Biosciences. It